Sunesis Pharmaceuticals, Inc. (SNSS) Reaches $4.01 After 3.00% Down Move; Passport Capital Has Raised Its Affiliated Managers Group (AMG) Position

March 14, 2018 - By Darrin Black

The stock of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) is a huge mover today! The stock decreased 5.65% or $0.24 during the last trading session, reaching $4.005. About 507,738 shares traded or 104.46% up from the average. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) has risen 8.33% since March 14, 2017 and is uptrending. It has underperformed by 8.37% the S&P500.The move comes after 6 months negative chart setup for the $137.16M company. It was reported on Mar, 14 by We have $3.88 PT which if reached, will make NASDAQ:SNSS worth $4.11M less.

Passport Capital Llc increased Affiliated Managers Group (AMG) stake by 6.13% reported in 2017Q3 SEC filing. Passport Capital Llc acquired 1,973 shares as Affiliated Managers Group (AMG)’s stock declined 9.34%. The Passport Capital Llc holds 34,156 shares with $6.48 million value, up from 32,183 last quarter. Affiliated Managers Group now has $10.55 billion valuation. The stock decreased 0.71% or $1.385 during the last trading session, reaching $193.565. About 105,813 shares traded. Affiliated Managers Group, Inc. (NYSE:AMG) has declined 5.60% since March 14, 2017 and is downtrending. It has underperformed by 22.30% the S&P500.

Passport Capital Llc decreased Parsley Energy Inc (NYSE:PE) stake by 1.11 million shares to 1.27M valued at $33.36M in 2017Q3. It also reduced Wingstop Inc stake by 81,407 shares and now owns 531,493 shares. Barclays Bk Plc (Prn) was reduced too.

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.22, from 0.91 in 2017Q2. It increased, as 34 investors sold AMG shares while 158 reduced holdings. 50 funds opened positions while 125 raised stakes. 49.56 million shares or 1.61% less from 50.37 million shares in 2017Q2 were reported. Tributary Cap Ltd accumulated 525 shares or 0.01% of the stock. Passport Cap Ltd invested in 34,156 shares or 1.79% of the stock. Kentucky Retirement Systems Tru Fund reported 0.05% of its portfolio in Affiliated Managers Group, Inc. (NYSE:AMG). Osborne Partners Cap Mgmt Limited Com has invested 0.11% of its portfolio in Affiliated Managers Group, Inc. (NYSE:AMG). Jane Street Limited Liability Company has invested 0% in Affiliated Managers Group, Inc. (NYSE:AMG). Ledyard Retail Bank reported 362 shares. Stephens Inc Ar owns 2,286 shares. Moreover, Twin Focus Cap Prtn Limited Liability Corp has 0.2% invested in Affiliated Managers Group, Inc. (NYSE:AMG). Bank Of Nova Scotia holds 0% of its portfolio in Affiliated Managers Group, Inc. (NYSE:AMG) for 20 shares. 149 are held by Washington Natl Bank. Glg Ltd Llc reported 6,850 shares. D E Shaw Co holds 0% of its portfolio in Affiliated Managers Group, Inc. (NYSE:AMG) for 12,489 shares. Brown Advisory Incorporated holds 0% of its portfolio in Affiliated Managers Group, Inc. (NYSE:AMG) for 2,903 shares. Texas Permanent School Fund has 0.04% invested in Affiliated Managers Group, Inc. (NYSE:AMG) for 15,508 shares. Nomura Hldgs holds 2,883 shares.

Since March 7, 2018, it had 0 buys, and 1 insider sale for $5.69 million activity. 30,000 Affiliated Managers Group, Inc. (NYSE:AMG) shares with value of $5.69M were sold by Horgen Jay C..

Among 10 analysts covering Affiliated Managers Group (NYSE:AMG), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Affiliated Managers Group had 49 analyst reports since August 9, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, July 11 by Jefferies. The rating was maintained by Keefe Bruyette & Woods on Thursday, December 21 with “Buy”. The firm has “Buy” rating given on Wednesday, April 5 by Wood. On Monday, April 25 the stock rating was upgraded by Citigroup to “Buy”. Deutsche Bank maintained the shares of AMG in report on Friday, September 18 with “Buy” rating. The company was maintained on Wednesday, June 14 by Jefferies. On Friday, August 11 the stock rating was maintained by Credit Suisse with “Outperform”. On Thursday, September 3 the stock rating was maintained by Wood with “Outperform”. Deutsche Bank maintained it with “Buy” rating and $190 target in Thursday, March 17 report. As per Friday, September 9, the company rating was maintained by Deutsche Bank.

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The company has market cap of $137.16 million. The firm is developing vosaroxin, an anticancer quinolone derivative for the treatment of acute myeloid leukemia . It currently has negative earnings. It has completed a Phase III, randomized, double-blind, and placebo-controlled trial of vosaroxin in combination with cytarabine in patients with relapsed or refractory AML.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.